Navigation Links
Obesity drug failing patients due to lack of education about side-effects
Date:5/8/2014

A new study, published today in the Journal of Health Psychology, found that patients who gained weight 18 months after taking Orlistat attributed their weight-loss failure either to the side effects which have prevented them from sticking to the medication or felt that the medication simply had not worked.

The team from the University of Surrey also found that participants described a series of barriers to weight loss including psychological and physical health issues, relationships and the make-up of their bodies. They also described a number of alternative methods of weight loss that had also failed, and the failure of Orlistat was included within this idea of permanent and ongoing failure.

Orlistat is currently the only prescribed drug for obesity and functions by reducing the amount of fat absorbed from food eaten.

"Our results have significant implications for GPs and how they should communicate with the patients about this drug," said lead author Dr Amelia Hollywood from the University of Surrey.

"GPs can improve patient support while taking Orlistat. At present, the so called "side effects" of Orlistat are seen as unpleasant and intrusive. If health professionals can highlight that such "side effects" are actually the consequences of eating high-fat foods while taking the drug, it could help ensure a change in diets.

"In addition, by alerting patients to these consequences and emphasising the need for dietary change, patients may be in a better position to make an informed judgement as to whether they wish to be prescribed this medication. GPs may likewise be able to make a more informed decision as to whether the medication should be prescribed, which could have cost implications for the NHS by reducing the waste of medications."


'/>"/>

Contact: Tanya Gubbay
t.gubbay@surrey.ac.uk
University of Surrey
Source:Eurekalert

Page: 1

Related medicine news :

1. Childhood obesity trends -- not time to celebrate, yet
2. Linking vascular inflammation to obesity and atherosclerosis
3. Snacking contributes to fatty liver and abdominal obesity
4. Early obesity linked to increased probability of severe obesity later in life
5. Motivational interviewing can positively impact childhood obesity
6. New myeloma-obesity research shows drugs can team with bodys defenses
7. Event to focus on obesity, diabetes and metabolic syndrome
8. Rules of thumb: 3 simple ideas for overcoming childhood obesity
9. Early-Life Influences on Obesity: From Pre-Conception to Adolescence
10. Discovery of anti-appetite molecule released by fiber could help tackle obesity
11. Study finds link between childs obesity and cognitive function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... 24, 2017 , ... Labs often perform the same operations ... operators and management to assess these processes with a critical eye—particularly in the ... , Created with the help of both internal and external process experts, ...
(Date:4/24/2017)... ... ... “Reflections of God’s Work”: an enlightening collection of life lessons leading each person ... author, Jerri Broglin, a survivor of great loss who gained insight on how to ... those searching for answers, as we are finding the answers that are so deep ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/24/2017)... ... 24, 2017 , ... Anaconda BioMed, a pre-clinical stage medical ... treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna Medical ... towards regulatory and clinical phases. , "This is another important step for Anaconda ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: